United States· US:13668-747_d75a5a57-6ab2-4aa3-abc5-de648ac84e65
sacubitril and valsartan
A angiotensin ii receptor blockers (arbs), other combinations product containing sacubitril and valsartan, registered in United States by Torrent Pharmaceuticals Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- sacubitril and valsartan
- Manufacturer
- Torrent Pharmaceuticals Limited
- Country
- United States (US)
- ATC code
- C09DX
- ATC class
- Angiotensin II receptor blockers (ARBs), other combinations
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 4
- ndc111366874705500 TABLET in 1 BOTTLE (13668-747-05)
- ndc111366874733180 TABLET in 1 BOTTLE (13668-747-33)
- ndc11136687476060 TABLET in 1 BOTTLE (13668-747-60)
- ndc111366874774100 BLISTER PACK in 1 CARTON (13668-747-74) / 10 TABLET in 1 BLISTER PACK (13668-747-71)
Regulatory notes
Same class
Other records under C09DX
Angiotensin ii receptor blockers (arbs), other combinations, as other registers publish it.
- United Statessacubitril and valsartanTorrent Pharmaceuticals Limited
- United Statessacubitril and valsartanTorrent Pharmaceuticals Limited
- United Statessacubitril and valsartanTorrent Pharmaceuticals Limited
- United Statessacubitril and valsartanTorrent Pharmaceuticals Limited
- United StatesSacubitril and ValsartanAmerican Health Packaging
- United StatesSacubitril and ValsartanAmerican Health Packaging
- United StatesSacubitril and ValsartanAmerican Health Packaging
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9509283d-498b-41a7-ad56-3495f97ed48e GET /v1/drugs/9509283d-498b-41a7-ad56-3495f97ed48e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "17ERJ0MKGI",
"rxcui": "1656328",
"inchikey": "PYNXFZCZUAOOQC-UTKZUKDTSA-N",
"display_name": "SACUBITRIL",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"a1fa7066-8ab4-47e3-a701-6c5170700d11": {
"match": "brand_token",
"title": "SACUBITRIL AND VALSARTAN TABLET, FILM COATED [ANI PHARMACEUTICALS, INC.]",
"spl_version": "2",
"published_date": "2026-05-28"
}
},
"productid": "13668-747_d75a5a57-6ab2-4aa3-abc5-de648ac84e65",
"productndc": "13668-747",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "213604",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "24MG;26MG",
"product_no": "001",
"approval_date": "Aug 22, 2024"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "49MG;51MG",
"product_no": "002",
"approval_date": "Aug 22, 2024"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "97MG;103MG",
"product_no": "003",
"approval_date": "Aug 22, 2024"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "SACUBITRIL; VALSARTAN",
"proprietary_name": "sacubitril and valsartan",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "ANDA213604",
"marketing_category": "ANDA",
"nonproprietary_name": "sacubitril and valsartan",
"start_marketing_date": "20250716",
"active_numerator_strength": "97; 103"
}See everything about sacubitril and valsartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.